Skip to main content
SpringerLink
Log in

A mouse/human chimeric anti-(ganglioside GD3) antibody with enhanced antitumor activities

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

Ganglioside GD3, which is one of the major gangliosides expressed on the cell surface of human tumors of neuroectodermal origin has been focused on as a target molecule for passive immunotherapy. We have cloned the cDNA encoding the immunoglobulin light and heavy chains of an anti-GD3 monoclonal antibody KM641 (murine IgG3, κ), and constructed the chimeric genes by linking the cDNA fragments of the murine light and heavy variable regions to cDNA fragments of the human κ and γ1 constant regions, respectively. The transfer of these cDNA constructs into SP2/0 mouse myeloma cells resulted in the production of the chimeric antibody, designated KM871, that retained specific binding activity to GD3. Indirect immunofluorescence revealed the same staining pattern for chimeric KM871 and the mouse counterpart KM641 on GD3-expressing melanoma cells. When human serum and human peripheral blood mononuclear cells were used as effectors in complement-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity respectively, the chimeric KM871 was more effective in killing GD3-expressing tumor cells than was the mouse counterpart KM641. Intravenous injection of chimeric KM871 markedly suppressed tumor growth in nude mice. The chimeric KM871, having enhanced antitumor activities and less immunogenicity than the mouse counterpart, would be a useful agent for passive immunotherapy of human cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bernhard H, Bauerschmitz J, Büschenfelde K-H, Dippold W (1992) Immunorecognition of different ganglioside epitopes on human normal and melanoma tissues. Int J Cancer 51: 568

    Google Scholar 

  2. Cheresh DA, Harper JR, Schulz G, Reisfeld RA (1984) Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells. Proc Natl Acad Sci USA 81: 5767

    Google Scholar 

  3. Cheung NV, Lazarus H, Miraldi FD (1987) Ganglioside GD2 specific monoclonal antibody 3F8: a phase-I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol 5: 1430

    Google Scholar 

  4. Dippold W, Lloyd KO, Li LTC, Ikeda H, Oettgen HF, Old LJ (1980) Cell-surface antigens of human malignant melanoma-definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci USA 77: 6114

    Google Scholar 

  5. Ellison JW, Berson BJ, Hood LE (1982) The nucleotide sequence of a human immunoglobulin Cγ1 gene. Nucleic Acids Res 10: 4071

    Google Scholar 

  6. Hakimi J, Chizzonite R, Luke DR, Familletti PC, Bailon P, Kondas JA, Pilson RS, Lin P, Weber DV, Spence C, Mondini LJ, Tsien W-H, Levin JL, Gallati VH, Korn L, Waldmann TA, Queen C, Benjamin WR (1991) Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys. J Immunol 147: 1352

    Google Scholar 

  7. Hanai N, Nores GA, MacLeod C, Torres-Mendez C-R, Hakomori S (1988) Ganglioside-mediated modulation of cell growth. J Biol Chem 263: 10915

    Google Scholar 

  8. Hanai N, Furuya A, Shitara K, Oda S, Yoshida H (1988) Comparative studies on monoclonal antibodies raised against human gastric cancer for application to serum diagnosis of cancer. Anticancer Res 8: 329

    Google Scholar 

  9. Hanai N, Shitara K, Furuya A, Yoshida H, Dohi T, Nudelman E, Hakomori S, Satoh S (1990) Detailed characterization of reactivities of anti-gastric cancer monoclonal antibodies to carbohydrate antigen. Anticancer Res 10: 1579

    Google Scholar 

  10. Hieter PA, Max EE, Seidman JG, Maizel JV Jr, Leder P (1980) Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments. Cell 22: 197

    Google Scholar 

  11. Hellström I, Brankovan V, Hellström KE (1985) Strong antitumor activities of IgG3 antibodies to a human melanoma-associated ganglioside. Proc Natl Acad Sci USA 82: 1499

    Google Scholar 

  12. Houghton AN, Mintzer D, Cordon-Cardo C, Welt S, Fliegel B, Vadham S, Carswell E, Melamed MR, Oettgen H, Old LJ (1985) Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase-I trial in patients with malignant melanoma. Proc Natl Acad Sci USA 82: 1242

    Google Scholar 

  13. Irie RF, Morton DL (1986) Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside. Proc Natl Acad Sci USA 83: 8694

    Google Scholar 

  14. Irie RF, Matsuki T, Morton DL (1989) Human monoclonal antibody to ganglioside GM2 for melanoma treatment. Lancet I: 786

    Google Scholar 

  15. Jennemann R, Rodden A, Bauer BL, Mennel H-D, Wiegandt H (1990) Glycosphingolipids of human gliomas. Cancer Res 50: 7444

    Google Scholar 

  16. Kameyama K, Imai K, Itoh T, Taniguchi M, Miura K, Kurosawa Y. Convenient plasmid vectors for construction of chimeric mouse/human antibodies. (1989) FEBS Lett 244: 301

    Google Scholar 

  17. Khazaeli MB, Saleh MN, Wheeler RH, Huster WJ, Holden H, Carrano R, LoBuglio AF (1988) Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune response. JNCI 80: 937

    Google Scholar 

  18. Kuwana Y, Asakura Y, Utsunomiya N, Nakanishi M, Arata Y, Itoh S, Nagase F, Kurosawa Y (1987) Expression of chimeric receptor composed of immunoglobulin-derived V lesions and T-cell receptorderived C lesions. Biochem Biophys Res Commun 149: 960

    Google Scholar 

  19. Liu AY, Robinson RR, Hellstrom KE, Murray ED Jr, Chang CP, Hellstrom I (1987) Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells. Proc Natl Acad Sci USA 84: 3439

    Google Scholar 

  20. LoBuglio AF, Wheeler RH, Trang J, Haynes A, Rogers K, Harvey EB, Sun L, Ghrayeb J, Khazaeli MB (1989) Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sci USA 86: 4220

    Google Scholar 

  21. Miyaji H, Mizukami T, Hosoi S, Sato S, Fujiyoshi N, Itoh S (1990) Expression of human beta-interferon in Namalwa KJM-1 which was adapted to serum-free medium. Cytotechnology 3: 133

    Google Scholar 

  22. Miyaji H, Harada N, Mizukami T, Sato S, Fujiyoshi N, Itoh S (1990) Efficient expression of human beta-interferon in Namalwa KJM-1 cells adapated to serum-free medium by a dhfr gene coamplification method. Cytotechnology 4: 173

    Google Scholar 

  23. Müeller BM, Romerdahl CA, Gillies SD, Reisfeld RA (1990) Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody. J Immunol 144: 1382

    Google Scholar 

  24. Nudelman E, Hakomori S, Kannagi R, Levery S, Yeh M-Y, Hellström KE, Hellström I (1982) Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2. J Biol Chem 257: 12 752

    Google Scholar 

  25. Ohta S, Honda A, Tokutake T, Yoshida H, Hanai N (1993) Antitumor effects of a novel monoclonal antibody with high binding-affinity to ganglioside GD3. Cancer Immunol Immunother (in press)

  26. Portoukalian J, Zwingelstein G, Dore J (1979) Lipid composition of human malignant melanoma tumors at various levels of malignant growth. Eur J Biochem 94: 19

    Google Scholar 

  27. Pukel CS, Lloyd KO, Travassor R, Dippold WG, Oettgen HF, Old LJ (1982) GD3, a prominent ganglioside of human melanoma. J Exp Med 155: 1133

    Google Scholar 

  28. Ravindranath MH, Tsuchida T, Morton DL, Irie RI (1991) Ganglioside GM3:GD3 ratio as an index for the management of melanoma. Cancer 67: 3029

    Google Scholar 

  29. Real FX, Houghton AN, Albino AP, Cordon-Cardo C, Melamed MR, Oettgen HF, Old LJ (1985) Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of expression in cultured cells and tissues. Cancer Res 45: 4401

    Google Scholar 

  30. Rinflet A, Horne C, Bour H, Markers A, Dorrington KJ, Klein M (1990) Isotype modulation of idiotypic expression in recombinant isotype variants of MOPC 315. J Immunol 145: 925

    Google Scholar 

  31. Roeder W, Maki R, Traunecker A, Tonegawa S (1981) Linkage of the four γ subclass heavy chain genes. Proc Natl Acad Sci USA 78: 474

    Google Scholar 

  32. Rosenberg JM, Sander DJ, Derango RE, Cheresh DA (1988) Enzymatic basis for increased expression of GD3 on human melanoma cells derived from metastatic lesions. J Clin Lab Anal 2: 91

    Google Scholar 

  33. Sakano H, Huppi K, Heinrich H, Tonegawa S (1979) Sequences at the somatic recombination sites of immunoglobulin light-chain genes. Nature 280: 288

    Google Scholar 

  34. Steplewski Z, Sun LK, Shearman CW, Ghrayeb J, Daddona P, Koprowski H (1988) Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity. Proc Natl Acad Sci USA 85: 4852

    Google Scholar 

  35. Tsuchida T, Saxton RE, Morton DL, Irie RF (1987) Gangliosides of human melanoma. JNCI 78: 45

    Google Scholar 

  36. Vadhan-Raj S, Cordon-Cardo C, Carswell E, Mintzer D, Dantis L, Duteau C, Templeton MA, Oettgen HF, Old LJ, Houghton AN (1988) Phase-I trial of a mouse monoclonal against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites. J Clin Oncol 6: 1636

    Google Scholar 

  37. Winter G, Milstein C (1991) Man-made antibodies. Nature 349: 293

    Google Scholar 

  38. Yates AJ, Thompson PK, Boesel CP, Albrightson C, Hart RW (1979) Lipid composition of human neural tumors. J Lipid Res 20: 428

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tokyo Research Laboratories, Kyowa Hakko Kogyo Co. Ltd., 3-6-6 Asahi-machi, 194, Machida, Tokyo, Japan

    Kenya Shitara, Yoshihisa Kuwana, Kazuyasu Nakamura, Yuko Tokutake, So Ohta, Hiromasa Miyaji, Mamoru Hasegawa & Nobuo Hanai

Authors
  1. Kenya Shitara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshihisa Kuwana
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazuyasu Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuko Tokutake
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. So Ohta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiromasa Miyaji
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mamoru Hasegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Nobuo Hanai
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shitara, K., Kuwana, Y., Nakamura, K. et al. A mouse/human chimeric anti-(ganglioside GD3) antibody with enhanced antitumor activities. Cancer Immunol Immunother 36, 373–380 (1993). https://doi.org/10.1007/BF01742253

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01742253

Key words

Search

Navigation